Combination Of Everolimus And Exemestane Improves Progression-Free Survival For Women
 

In an international Phase III randomized study, everolimus, when combined with the hormonal therapy exemestane, has been shown to dramatically improve progression-free survival, according to research from The University of Texas MD Anderson Cancer Center...

More...